-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$31.5097.12% Upside
Cullinan Oncology, Inc. Frequently Asked Questions
-
What analysts cover Cullinan Oncology, Inc.?
Cullinan Oncology, Inc. has been rated by research analysts at UBS, Morgan Stanley, H.C. Wainwright, BTIG in the past 90 days.